SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Claude Robitaille who wrote (551)4/16/1999 1:17:00 PM
From: StockMiser  Read Replies (1) of 2344
 
As a side note....

Of course the courts dismissed Alrarex's request for "Biomira to produce evidence of their claims". Biomira owns the freakin patent already, and the presumption is that their claim is valid (in fact, it is undisputed). The question is whether or not Altarex's invention infringes on that patent. Biomira isn't obligated to hand over additional proprietary information to a company accused of stealing their patent.

All of the presumptions are in Biomira's favor. As I've said before, the basis of the science in question pre-dates the existance of Altarex. Altarex will have to prove that their invention is unique from the existing patented invention by Biomira. Biomira is EXTREMELY confident that Altarex cannot do that.

SM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News